EQUIVIR-G Trademark

Trademark Overview

On Wednesday, February 23, 2022, a trademark application was filed for EQUIVIR-G with the United States Patent and Trademark Office. The USPTO has given the EQUIVIR-G trademark a serial number of 97280932. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 16, 2025. This trademark is owned by Global Biolife, Inc.. The EQUIVIR-G trademark is filed in the Pharmaceutical Products category with the following description:

antivirals, excluding antivirals for the treatment and prevention of hepatitis B, HIV, or AIDS; pharmaceutical preparations, namely, antivirals, excluding antivirals for the treatment and prevention of hepatitis B, HIV, or AIDS
equivir-g

General Information

Serial Number97280932
Word MarkEQUIVIR-G
Filing DateWednesday, February 23, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and Servicesantivirals, excluding antivirals for the treatment and prevention of hepatitis B, HIV, or AIDS; pharmaceutical preparations, namely, antivirals, excluding antivirals for the treatment and prevention of hepatitis B, HIV, or AIDS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobal Biolife, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77084
Party NameGlobal Biolife, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77084

Trademark Events

Event DateEvent Description
Tuesday, March 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 26, 2022NEW APPLICATION ENTERED
Thursday, August 31, 2023ASSIGNED TO EXAMINER
Thursday, March 24, 2022ASSIGNED TO EXAMINER
Friday, April 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 1, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 6, 2022OPPOSITION INSTITUTED NO. 999999
Wednesday, June 5, 2024OPPOSITION DISMISSED NO. 999999
Wednesday, June 5, 2024OPPOSITION TERMINATED NO. 999999
Wednesday, June 5, 2024TTAB RELEASE CASE TO TRADEMARKS
Thursday, June 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 27, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, June 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 13, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 2, 2025SOU EXTENSION 1 FILED
Thursday, January 2, 2025SOU EXTENSION 1 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 16, 2025SOU EXTENSION 2 FILED
Wednesday, July 16, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, July 16, 2025SOU EXTENSION 2 GRANTED
Thursday, July 17, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 1, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

equivir antivirals aids prevention hepatitis treatment excluding namely pharmaceutical preparations